Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Asset Utilization Ratio (2011 - 2026)

Harvard Bioscience (HBIO) reported Asset Utilization Ratio of 1.08 for Q1 2026, up 22.27% year-over-year from 0.89 in Q1 2025, and down 1.14% on a QoQ basis from 1.1 in Q4 2025.

Harvard Bioscience (HBIO) has 16 years of Asset Utilization Ratio data on file, last reported at 1.08 in Q1 2026.

  • Quarterly Asset Utilization Ratio rose 22.27% year-over-year to 1.08 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 1.08 (up 22.27% YoY) and the FY2025 annual result came in at 0.84, up 17.43% from the prior year.
  • Asset Utilization Ratio eased to 1.08 in Q1 2026 per HBIO's latest filing, from 1.1 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 1.11 in Q2 2025 and bottomed at 0.73 in Q4 2024.
  • The 5-year median for Asset Utilization Ratio is 0.79 (2024), against an average of 0.86.
  • The widest annual swing landed in 2024, when Asset Utilization Ratio retreated 9.89%; it then surged 50.01% in 2025.
  • Tracing HBIO's Asset Utilization Ratio over 5 years: stood at 0.78 in 2022, then advanced by 4.5% to 0.81 in 2023, then slipped by 9.89% to 0.73 in 2024, then jumped by 50.01% to 1.1 in 2025, then declined by 1.14% to 1.08 in 2026.
  • Per Business Quant, the three latest HBIO Asset Utilization Ratio figures stand at 1.08 (Q1 2026), 1.1 (Q4 2025), and 1.11 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 0.52
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 0.40
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 0.64
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 0.77
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.58
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.33
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 0.65
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 0.54
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 0.75
10 Harvard Bioscience 25.38 Mn 18.29 Mn 12.24 Mn 1.08

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.08
Dec 31, 2025 1.10
Sep 30, 2025 1.11
Jun 30, 2025 1.11
Mar 31, 2025 0.89
Dec 31, 2024 0.73
Sep 30, 2024 0.75
Jun 30, 2024 0.77
Mar 31, 2024 0.79
Dec 31, 2023 0.81
Sep 30, 2023 0.80
Jun 30, 2023 0.79
Mar 31, 2023 0.79
Dec 31, 2022 0.78
Sep 30, 2022 0.78
Jun 30, 2022 0.77
Mar 31, 2022 0.75
Dec 31, 2021 0.75
Sep 30, 2021 0.76
Jun 30, 2021 0.73
Mar 31, 2021 0.68
Dec 31, 2020 0.67
Sep 30, 2020 0.68
Jun 30, 2020 0.69
Mar 31, 2020 0.70
Dec 31, 2019 0.71
Sep 30, 2019 0.72
Jun 30, 2019 0.71
Mar 31, 2019 0.72
Dec 31, 2018 0.72
Sep 30, 2018 0.66
Jun 30, 2018 0.59
Mar 31, 2018 0.61
Dec 31, 2017 0.70
Sep 30, 2017 0.75
Jun 30, 2017 0.82
Mar 31, 2017 0.89
Dec 31, 2016 0.95
Sep 30, 2016 0.94
Jun 30, 2016 0.92
Mar 31, 2016 0.92
Dec 31, 2015 0.86
Sep 30, 2015 0.81
Jun 30, 2015 0.81
Mar 31, 2015 0.80
Dec 31, 2014 0.80
Sep 30, 2014 0.78
Jun 30, 2014 0.78
Mar 31, 2014 0.78
Dec 31, 2013 0.74
Sep 30, 2013 0.72
Jun 30, 2013 0.76
Mar 31, 2013 0.81
Dec 31, 2012 0.84
Sep 30, 2012 0.86
Jun 30, 2012 0.86
Mar 31, 2012 0.86
Dec 31, 2011 0.86
Sep 30, 2011 0.85